← FDA DRUG APPROVALS

FDA NDA · NDA019329

SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER

Sponsor: ABRAXIS PHARM

APPLICATION
NDA019329
TYPE
NDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER · ReferenceDiscontinued
SODIUM CHLORIDE 234MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →